FDA Approves Drug to Treat Severe Malaria

Latest Infectious Disease News

WEDNESDAY, May 27, 2020 (HealthDay News) — A drug to deal with extreme malaria in adults and kids has been accepted by the U.S. Food and Drug Administration.

There hasn’t been an FDA-approved drug to deal with extreme malaria since quinidine was discontinued by the producer in March 2019.

The new approval is for intravenous (IV) artesunate, which ought to at all times be adopted by a whole therapy course of an applicable oral antimalarial remedy, the FDA mentioned.

“This approval will now give sufferers extra entry to a lifesaving drug,” Dr. John Farley, appearing director of the Office of Infectious Diseases within the FDA’s Center for Drug Evaluation and Research, mentioned in an company information launch.

About 2,000 malaria instances are identified annually within the United States, and about 300 are extreme instances, in keeping with the Centers for Disease Control and Prevention. Most U.S. instances happen in individuals who’ve traveled to international locations with malaria.

MedicalNews
Copyright © 2019 HealthDay. All rights reserved.